MAP1B and neoplasm: LAMA2, MAP1B, and HIP1R were among the genes with higher mutation frequencies (8%, 6%, and 5%, respectively), suggesting these mutations play a crucial part in tumor initiation and progression, and these genes could be potential driver genes or therapeutic targets.